As technology continues to evolve, bringing AI, advanced imaging, and novel sampling techniques into routine practice, the ...

Key Takeaways GLP-1 drugs might increase a person’s risk of severe acid refluxPeople with type 2 diabetes taking GLP-1 drugs ...

Cancer deaths linked to obesity more than tripled in the United States during the past two decades, a new study says.

Invikafusp alfa, a dual T-cell agonist targeting subsets of tumor-infiltrating lymphocytes, can elicit responses in patients with heavily pretreated gastrointestinal cancers, according to research ...

Key Takeaways Cancer deaths linked to obesity have more than tripled in two decadesRates rose to 13.5 deaths per million from ...

TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).

Half of all cancer deaths worldwide are attributable to modifiable risk factors, according to The Cancer Atlas.

A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

This year, more than 22,000 Americans face a chilling diagnosis — esophageal cancer. A new 3-minute in-office test is ...